Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
Open accessThe DOI matches its Crossref record; 375 of the 375 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To provide an update to the original Surviving Sepsis Campaign clinical management guidelines, "Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock," published in 2004. DESIGN: Modified Delphi method with a consensus conference of 55 international experts, several subsequent meetings of subgroups and key individuals, teleconferences, and electronic-based discussion among subgroups and among the entire committee. This process was conducted independently of any industry funding. METHODS: We used the GRADE system to guide assessment of quality of evidence from high (A) to very low (D) and to determine the strength of recommendations. A strong recommendation indicates that an intervention's desirable effects clearly outweigh its undesirable effects (risk, burden, cost), or clearly do not. Weak recommendations indicate that the tradeoff between desirable and undesirable effects is less clear. The grade of strong or weak is considered of greater clinical importance than a difference in letter level of quality of evidence. In areas without complete agreement, a formal process of resolution was developed and applied. Recommendations are grouped into those directly targeting severe sepsis, recommendations targeting general care of the critically ill patient that are considered high priority in severe sepsis, and pediatric considerations. RESULTS: Key recommendations, listed by category, include: early goal-directed resuscitation of the septic patient during the first 6 hrs after recognition (1C); blood cultures prior to antibiotic therapy (1C); imaging studies performed promptly to confirm potential source of infection (1C); administration of broad-spectrum antibiotic therapy within 1 hr of diagnosis of septic shock (1B) and severe sepsis without septic shock (1D); reassessment of antibiotic therapy with microbiology and clinical data to narrow coverage, when appropriate (1C); a usual 7-10 days of antibiotic therapy guided by clinical response (1D); source control with attention to the balance of risks and benefits of the chosen method (1C); administration of either crystalloid or colloid fluid resuscitation (1B); fluid challenge to restore mean circulating filling pressure (1C); reduction in rate of fluid administration with rising filing pressures and no improvement in tissue perfusion (1D); vasopressor preference for norepinephrine or dopamine to maintain an initial target of mean arterial pressure > or = 65 mm Hg (1C); dobutamine inotropic therapy when cardiac output remains low despite fluid resuscitation and combined inotropic/vasopressor therapy (1C); stress-dose steroid therapy given only in septic shock after blood pressure is identified to be poorly responsive to fluid and vasopressor therapy (2C); recombinant activated protein C in patients with severe sepsis and clinical assessment of high risk for death (2B except 2C for post-operative patients). In the absence of tissue hypoperfusion, coronary artery disease, or acute hemorrhage, target a hemoglobin of 7-9 g/dL (1B); a low tidal volume (1B) and limitation of inspiratory plateau pressure strategy (1C) for acute lung injury (ALI)/acute respiratory distress syndrome (ARDS); application of at least a minimal amount of positive end-expiratory pressure in acute lung injury (1C); head of bed elevation in mechanically ventilated patients unless contraindicated (1B); avoiding routine use of pulmonary artery catheters in ALI/ARDS (1A); to decrease days of mechanical ventilation and ICU length of stay, a conservative fluid strategy for patients with established ALI/ARDS who are not in shock (1C); protocols for weaning and sedation/analgesia (1B); using either intermittent bolus sedation or continuous infusion sedation with daily interruptions or lightening (1B); avoidance of neuromuscular blockers, if at all possible (1B); institution of glycemic control (1B) targeting a blood glucose < 150 mg/dL after initial stabilization ( 2C ); equivalency of continuous veno-veno hemofiltration or intermittent hemodialysis (2B); prophylaxis for deep vein thrombosis (1A); use of stress ulcer prophylaxis to prevent upper GI bleeding using H2 blockers (1A) or proton pump inhibitors (1B); and consideration of limitation of support where appropriate (1D). Recommendations specific to pediatric severe sepsis include: greater use of physical examination therapeutic end points (2C); dopamine as the first drug of choice for hypotension (2C); steroids only in children with suspected or proven adrenal insufficiency (2C); a recommendation against the use of recombinant activated protein C in children (1B). CONCLUSION: There was strong agreement among a large cohort of international experts regarding many level 1 recommendations for the best current care of patients with severe sepsis. Evidenced-based recommendations regarding the acute management of sepsis and septic shock are the first step toward improved outcomes for this important group of
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Self-citation(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Self-citationGrading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Self-citationCenters for Disease Control and Prevention
(2007) · Encyclopedia of Measurement and Statistics · doi:10.4135/9781412952644.n74 · Cited by 6,444
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Self-citationKumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
Self-citation
Cited by
Items 101–200 of 295
Septic shock attributed to Candida infection: Importance of empiric therapy and source control.
Kollef, M., Micek, S., Hampton, N., Doherty, J. A., & Kumar, A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis305 · Cited by 477
Diastolic dysfunction and mortality in severe sepsis and septic shock
Landesberg, G., Gilon, D., Meroz, Y., Georgieva, M., Levin, P. D., Goodman, S., Avidan, A., Beeri, R., Weissman, C., Jaffe, A. S., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr351 · Cited by 472
Rosário, C., Zandman-Goddard, G., Meyron-Holtz, E. G., D’Cruz, D. P., & Shoenfeld, Y. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-185 · Cited by 466
Kumar, A., Zarychanski, R., Light, B., Parrillo, J., Maki, D., Simon, D., Laporta, D., Lapinsky, S., Ellis, P., Mirzanejad, Y., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181eb3ccd · Cited by 462
Legrand, M., Dupuis, C., Simon, C., Gayat, E., Mateo, J., Lukaszewicz, A.-C., & Payen, D. (2013) · Critical Care · doi:10.1186/cc13133 · Cited by 458
Gatta, A., Verardo, A., & Bolognesi, M. (2012) · Internal and Emergency Medicine · doi:10.1007/s11739-012-0802-0 · Cited by 456
Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
Iskander, K. N., Osuchowski, M. F., Stearns-Kurosawa, D. J., Kurosawa, S., Stepien, D., Valentine, C., & Remick, D. G. (2013) · Physiological Reviews · doi:10.1152/physrev.00037.2012 · Cited by 453
Flowers, C. R., Seidenfeld, J., Bow, E. J., Karten, C., Gleason, C., Hawley, D. K., Kuderer, N. M., Langston, A. A., Marr, K. A., Rolston, K. V. I., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.8661 · Cited by 448
Gustot, T., Durand, F., Lebrec, D., Vincent, J., & Moreau, R. (2009) · Hepatology · doi:10.1002/hep.23264 · Cited by 447
Self-citationSepsis: A Review of Advances in Management
Rello, J., Valenzuela-Sánchez, F., Ruiz-Rodriguez, M., & Moyano, S. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0622-8 · Cited by 443
The Importance of Fluid Management in Acute Lung Injury Secondary to Septic Shock
Murphy, C. V., Schramm, G. E., Doherty, J. A., Reichley, R. M., Gajic, O., Afessa, B., Micek, S. T., & Kollef, M. H. (2009) · Chest · doi:10.1378/chest.08-2706 · Cited by 441
Levitov, A., Frankel, H. L., Blaivas, M., Kirkpatrick, A. W., Su, E., Evans, D., Summerfield, D. T., Slonim, A., Breitkreutz, R., Price, S., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001847 · Cited by 440
Hypoglycemia and outcome in critically ill patients
Egi, M., Bellomo, R., Stachowski, E., French, C. J., Hart, G. K., Taori, G., Hegarty, C., & Bailey, M. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0394 · Cited by 432
Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential
Becker, B. F., Chappell, D., Bruegger, D., Annecke, T., & Jacob, M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq137 · Cited by 438
Tabah, A., Koulenti, D., Laupland, K., Misset, B., Valles, J., Bruzzi de Carvalho, F., Paiva, J. A., Çakar, N., Ma, X., Eggimann, P., et al. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2695-9 · Cited by 436
Self-citationEffectiveness of treatments for severe sepsis: A prospective, multicenter, observational study.
Ferrer, R., Artigas, A., Suarez, D., Palencia, E., Levy, M. M., Arenzana, A., Pérez, X. L., & Sirvent, J.-M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1912oc · Cited by 433
Self-citationGlucose variability and mortality in patients with sepsis*
Ali, N. A., OʼBrien, J. M., Dungan, K., Phillips, G., Marsh, C. B., Lemeshow, S., Connors, A. F., & Preiser, J.-C. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181810378 · Cited by 432
Clinical review: Update on hemodynamic monitoring - a consensus of 16
Vincent, J.-L., Rhodes, A., Perel, A., Martin, G. S., Rocca, G., Vallet, B., Pinsky, M. R., Hofer, C. K., Teboul, J.-L., de Boode, W.-P., et al. (2011) · Critical Care · doi:10.1186/cc10291 · Cited by 419
Self-citationGale, S. C., Shafi, S., Dombrovskiy, V. Y., Arumugam, D., & Crystal, J. S. (2014) · Journal of Trauma and Acute Care Surgery · doi:10.1097/ta.0000000000000362 · Cited by 415
Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients
Udy, A. A., Varghese, J. M., Altukroni, M., Briscoe, S., McWhinney, B. C., Ungerer, J. P., Lipman, J., & Roberts, J. A. (2012) · Chest · doi:10.1378/chest.11-1671 · Cited by 414
The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine
Chen, H., Bai, C., & Wang, X. (2010) · Expert Review of Respiratory Medicine · doi:10.1586/ers.10.71 · Cited by 409
The Era of Molecular and Other Non-Culture-Based Methods in Diagnosis of Sepsis
Mancini, N., Carletti, S., Ghidoli, N., Cichero, P., Burioni, R., & Clementi, M. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-09 · Cited by 407
TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos)
Yokoe, M., Takada, T., Strasberg, S. M., Solomkin, J. S., Mayumi, T., Gomi, H., Pitt, H. A., Garden, O. J., Kiriyama, S., Hata, J., et al. (2013) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-012-0568-9 · Cited by 405
Arnold, R. C., Shapiro, N. I., Jones, A. E., Schorr, C., Pope, J., Casner, E., Parrillo, J. E., Dellinger, R. P., & Trzeciak, S. (2009) · Shock · doi:10.1097/shk.0b013e3181971d47 · Cited by 400
Self-citationImpact of albumin compared to saline on organ function and mortality of patients with severe sepsis
The SAFE Study Investigators (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2039-6 · Cited by 399
Rhodes, A., Phillips, G., Beale, R., Cecconi, M., Chiche, J. D., De Backer, D., Divatia, J., Du, B., Evans, L., Ferrer, R., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3906-y · Cited by 398
Self-citation2016 WSES guidelines on acute calculous cholecystitis
Ansaloni, L., Pisano, M., Coccolini, F., Peitzmann, A. B., Fingerhut, A., Catena, F., Agresta, F., Allegri, A., Bailey, I., Balogh, Z. J., et al. (2016) · World Journal of Emergency Surgery · doi:10.1186/s13017-016-0082-5 · Cited by 395
Dulhunty, J. M., Roberts, J. A., Davis, J. S., Webb, S. A. R., Bellomo, R., Gomersall, C., Shirwadkar, C., Eastwood, G. M., Myburgh, J., Paterson, D. L., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis856 · Cited by 394
Dopamine versus norepinephrine in the treatment of septic shock: A meta-analysis*
De Backer, D., Aldecoa, C., Njimi, H., & Vincent, J.-L. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31823778ee · Cited by 389
Self-citationAttributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
Borer, A., Saidel-Odes, L., Riesenberg, K., Eskira, S., Peled, N., Nativ, R., Schlaeffer, F., & Sherf, M. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/605922 · Cited by 389
Garnacho-Montero, J., Gutiérrez-Pizarraya, A., Escoresca-Ortega, A., Corcia-Palomo, Y., Fernández-Delgado, E., Herrera-Melero, I., Ortiz-Leyba, C., & Márquez-Vácaro, J. A. (2014) · Intensive Care Medicine · doi:10.1007/s00134-013-3077-7 · Cited by 389
Glycocalyx and sepsis-induced alterations in vascular permeability
Chelazzi, C., Villa, G., Mancinelli, P., De Gaudio, A. R., & Adembri, C. (2015) · Critical Care · doi:10.1186/s13054-015-0741-z · Cited by 389
Molecular biology of inflammation and sepsis: A primer*
Cinel, I., & Opal, S. M. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819267fb · Cited by 387
Hydroxyethyl Starches: Different Products – Different Effects
Westphal, M., James, M. F. M., Kozek-Langenecker, S., Stocker, R., Guidet, B., Van Aken, H., & Warner, M. A. (2009) · Anesthesiology · doi:10.1097/aln.0b013e3181a7ec82 · Cited by 383
Augmented Renal Clearance: Implications for Antibacterial Dosing in the Critically Ill
Udy, A. A., Roberts, J. A., Boots, R. J., Paterson, D. L., & Lipman, J. (2010) · Clinical Pharmacokinetics · doi:10.2165/11318140-000000000-00000 · Cited by 377
Paul, M., Lador, A., Grozinsky-Glasberg, S., & Leibovici, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub3 · Cited by 377
Puskarich, M. A., Trzeciak, S., Shapiro, N. I., Arnold, R. C., Horton, J. M., Studnek, J. R., Kline, J. A., & Jones, A. E. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821e87ab · Cited by 376
Sepsis-Associated Acute Kidney Injury
Alobaidi, R., Basu, R. K., Goldstein, S. L., & Bagshaw, S. M. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.01.002 · Cited by 374
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock
Taccone, F. S., Laterre, P.-F., Dugernier, T., Spapen, H., Delattre, I., Wittebole, X., De Backer, D., Layeux, B., Wallemacq, P., Vincent, J.-L., et al. (2010) · Critical Care · doi:10.1186/cc9091 · Cited by 369
Self-citationManagement of bacterial infections in cirrhosis
Fernández, J., & Gustot, T. (2012) · Journal of Hepatology · doi:10.1016/s0168-8278(12)60002-6 · Cited by 368
Zhai, Z., Li, C., Chen, Y., Gerotziafas, G., Zhang, Z., Wan, J., Liu, P., Elalamy, I., Wang, C., & On behalf of the Prevention Treatment of VTE Associated with COVID-19 Infection Consensus Statement Group (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1710019 · Cited by 365
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…make it very clear indeed that iron is inti- mately involved in the death following SIRS and sepsis, and—while not even mentioned in the guidelines (Dellinger et al. 2008)—that its effective chelation should be consi- dered for research leading towards its inclusion as an important part of any…”
BackgroundMottling score predicts survival in septic shock
Ait-Oufella, H., Lemoinne, S., Boelle, P. Y., Galbois, A., Baudel, J. L., Lemant, J., Joffre, J., Margetis, D., Guidet, B., Maury, E., et al. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2163-y · Cited by 360
Weijs, P. J., Looijaard, W. G., Beishuizen, A., Girbes, A. R., & Oudemans-van Straaten, H. M. (2014) · Critical Care · doi:10.1186/s13054-014-0701-z · Cited by 358
Predisposing Factors for Adrenal Insufficiency
Bornstein, S. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804635 · Cited by 356
Epidemiology of Acute Kidney Injury in the Intensive Care Unit
Case, J., Khan, S., Khalid, R., & Khan, A. (2013) · Critical Care Research and Practice · doi:10.1155/2013/479730 · Cited by 357
Jensen, J. U., Hein, L., Lundgren, B., Bestle, M. H., Mohr, T. T., Andersen, M. H., Thornberg, K. J., Løken, J., Steensen, M., Fox, Z., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821e8791 · Cited by 356
Why we should be wary of single-center trials
Bellomo, R., Warrillow, S. J., & Reade, M. C. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181bc7bd5 · Cited by 355
Delaney, A. P., Dan, A., McCaffrey, J., & Finfer, S. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181ffe217 · Cited by 351
Wynn, J. L. (2016) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000315 · Cited by 348
Guidet, B., Martinet, O., Boulain, T., Philippart, F., Poussel, J., Maizel, J., Forceville, X., Feissel, M., Hasselmann, M., Heininger, A., et al. (2012) · Critical Care · doi:10.1186/cc11358 · Cited by 344
Schlapbach, L. J., Straney, L., Alexander, J., MacLaren, G., Festa, M., Schibler, A., & Slater, A. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71003-5 · Cited by 338
Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial Infarction
Saaby, L., Poulsen, T. S., Hosbond, S., Larsen, T. B., Pyndt Diederichsen, A. C., Hallas, J., Thygesen, K., & Mickley, H. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.02.029 · Cited by 336
The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort study
Daniels, R., Nutbeam, T., McNamara, G., & Galvin, C. (2011) · Emergency Medicine Journal · doi:10.1136/emj.2010.095067 · Cited by 335
Emerging Technologies for Molecular Diagnosis of Sepsis
Sinha, M., Jupe, J., Mack, H., Coleman, T. P., Lawrence, S. M., & Fraley, S. I. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00089-17 · Cited by 331
Cardiac dysfunction in severe sepsis and septic shock
Zanotti-Cavazzoni, S. L., & Hollenberg, S. M. (2009) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3283307a4e · Cited by 331
The Neutrophil-Lymphocyte Count Ratio in Patients with Community-Acquired Pneumonia
de Jager, C. P. C., Wever, P. C., Gemen, E. F. A., Kusters, R., van Gageldonk-Lafeber, A. B., van der Poll, T., & Laheij, R. J. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046561 · Cited by 328
Cirrhotic Patients Are at Risk for Health Care–Associated Bacterial Infections
Merli, M., Lucidi, C., Giannelli, V., Giusto, M., Riggio, O., Falcone, M., Ridola, L., Attili, A. F., & Venditti, M. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.06.024 · Cited by 324
Effects of fluids on microvascular perfusion in patients with severe sepsis
Ospina-Tascon, G., Neves, A. P., Occhipinti, G., Donadello, K., Büchele, G., Simion, D., Chierego, M.-L., Silva, T. O., Fonseca, A., Vincent, J.-L., et al. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1843-3 · Cited by 323
Self-citationHepatic abscess: Diagnosis and management
Lardière-Deguelte, S., Ragot, E., Amroun, K., Piardi, T., Dokmak, S., Bruno, O., Appere, F., Sibert, A., Hoeffel, C., Sommacale, D., et al. (2015) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2015.01.013 · Cited by 319
The changing immune system in sepsis: Is individualized immuno-modulatory therapy the answer?
Boomer, J. S., Green, J. M., & Hotchkiss, R. S. (2014) · Virulence · doi:10.4161/viru.26516 · Cited by 317
Nagdev, A. D., Merchant, R. C., Tirado-Gonzalez, A., Sisson, C. A., & Murphy, M. C. (2010) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2009.04.021 · Cited by 317
2013 WSES guidelines for management of intra-abdominal infections
Sartelli, M., Viale, P., Catena, F., Ansaloni, L., Moore, E., Malangoni, M., Moore, F. A., Velmahos, G., Coimbra, R., Ivatury, R., et al. (2013) · World Journal of Emergency Surgery · doi:10.1186/1749-7922-8-3 · Cited by 314
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
Alejandria, M. M., Lansang, M. A. D., Dans, L. F., & Mantaring III, J. B. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001090 · Cited by 313
Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study
Endo, S., Suzuki, Y., Takahashi, G., Shozushima, T., Ishikura, H., Murai, A., Nishida, T., Irie, Y., Miura, M., Iguchi, H., et al. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0435-2 · Cited by 311
Prognostic utility and characterization of cell-free DNA in patients with severe sepsis
Dwivedi, D. J., Toltl, L. J., Swystun, L. L., Pogue, J., Liaw, K.-L., Weitz, J. I., Cook, D. J., Fox-Robichaud, A. E., Liaw, P. C., & the Canadian Critical Care Translational Biology Group (2012) · Critical Care · doi:10.1186/cc11466 · Cited by 306
Time for a Neonatal-Specific Consensus Definition for Sepsis
Wynn, J. L., Wong, H. R., Shanley, T. P., Bizzarro, M. J., Saiman, L., & Polin, R. A. (2014) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000157 · Cited by 303
Gaieski, D. F., Band, R. A., Abella, B. S., Neumar, R. W., Fuchs, B. D., Kolansky, D. M., Merchant, R. M., Carr, B. G., Becker, L. B., Maguire, C., et al. (2009) · Resuscitation · doi:10.1016/j.resuscitation.2008.12.015 · Cited by 303
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
Alejandria, M. M., Lansang, M. A. D., Dans, L. F., & Mantaring III, J. B. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001090.pub2 · Cited by 302
Early versus delayed administration of norepinephrine in patients with septic shock
Bai, X., Yu, W., Ji, W., Lin, Z., Tan, S., Duan, K., Dong, Y., Xu, L., & Li, N. (2014) · Critical Care · doi:10.1186/s13054-014-0532-y · Cited by 301
Review: Viral infections and mechanisms of thrombosis and bleeding
Goeijenbier, M., van Wissen, M., van de Weg, C., Jong, E., Gerdes, V. E. A., Meijers, J. C. M., Brandjes, D. P. M., & van Gorp, E. C. M. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23354 · Cited by 299
Schuetz, P., Birkhahn, R., Sherwin, R., Jones, A. E., Singer, A., Kline, J. A., Runyon, M. S., Self, W. H., Courtney, D. M., Nowak, R. M., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002321 · Cited by 296
Clinical review: The liver in sepsis
Nesseler, N., Launey, Y., Aninat, C., Morel, F., Mallédant, Y., & Seguin, P. (2012) · Critical Care · doi:10.1186/cc11381 · Cited by 293
The function of neutrophils in sepsis
Kovach, M. A., & Standiford, T. J. (2012) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283528c9b · Cited by 293
Patel, A., Laffan, M. A., Waheed, U., & Brett, S. J. (2014) · BMJ · doi:10.1136/bmj.g4561 · Cited by 291
Daneman, N., Sarwar, S., Fowler, R. A., & Cuthbertson, B. H. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70322-5 · Cited by 288
Beyond Low Plasma T3: Local Thyroid Hormone Metabolism during Inflammation and Infection
Boelen, A., Kwakkel, J., & Fliers, E. (2011) · Endocrine Reviews · doi:10.1210/er.2011-0007 · Cited by 287
J. Romero-Bermejo, F., Ruiz-Bailen, M., Gil-Cebrian, J., & J. Huertos-Ranchal, M. (2011) · Current Cardiology Reviews · doi:10.2174/157340311798220494 · Cited by 287
Lee, V. S., Kawamoto, K., Hess, R., Park, C., Young, J., Hunter, C., Johnson, S., Gulbransen, S., Pelt, C. E., Horton, D. J., et al. (2016) · JAMA · doi:10.1001/jama.2016.12226 · Cited by 284
Respiratory Manifestations of Malaria
Taylor, W. R. J., Hanson, J., Turner, G. D. H., White, N. J., & Dondorp, A. M. (2012) · Chest · doi:10.1378/chest.11-2655 · Cited by 280
Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study
Levy, M. M., Rhodes, A., Phillips, G. S., Townsend, S. R., Schorr, C. A., Beale, R., Osborn, T., Lemeshow, S., Chiche, J.-D., Artigas, A., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3496-0 · Cited by 279
Self-citationBundled care for septic shock: An analysis of clinical trials*
Barochia, A. V., Cui, X., Vitberg, D., Suffredini, A. F., OʼGrady, N. P., Banks, S. M., Minneci, P., Kern, S. J., Danner, R. L., Natanson, C., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cb0ddf · Cited by 279
Micek, S. T., Welch, E. C., Khan, J., Pervez, M., Doherty, J. A., Reichley, R. M., & Kollef, M. H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01365-09 · Cited by 278
Hospital Characteristics Associated with Failure to Rescue from Complications after Pancreatectomy
Ghaferi, A. A., Osborne, N. H., Birkmeyer, J. D., & Dimick, J. B. (2010) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2010.04.025 · Cited by 277
Keh, D., Trips, E., Marx, G., Wirtz, S. P., Abduljawwad, E., Bercker, S., Bogatsch, H., Briegel, J., Engel, C., Gerlach, H., et al. (2016) · JAMA · doi:10.1001/jama.2016.14799 · Cited by 277
Self-citationSepsis 2018: Definitions and Guideline Changes
Napolitano, L. M. (2018) · Surgical Infections · doi:10.1089/sur.2017.278 · Cited by 275
Association between Source of Infection and Hospital Mortality in Patients Who Have Septic Shock
Leligdowicz, A., Dodek, P. M., Norena, M., Wong, H., Kumar, A., & Kumar, A. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201310-1875oc · Cited by 274
Animal models of sepsis: Why does preclinical efficacy fail to translate to the clinical setting?
Dyson, A., & Singer, M. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181922bd3 · Cited by 273
Pope, J. V., Jones, A. E., Gaieski, D. F., Arnold, R. C., Trzeciak, S., & Shapiro, N. I. (2010) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2009.08.014 · Cited by 273
2020 ACC/AHA guideline for the management of patients with valvular heart disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.002 · Cited by 279
Schefold, J. C., Bierbrauer, J., & Weber-Carstens, S. (2010) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-010-0010-6 · Cited by 268
Early Anticoagulation Is Associated With Reduced Mortality for Acute Pulmonary Embolism
Smith, S. B., Geske, J. B., Maguire, J. M., Zane, N. A., Carter, R. E., & Morgenthaler, T. I. (2010) · Chest · doi:10.1378/chest.09-0959 · Cited by 267
Diagnosis of ventilator-associated pneumonia: a systematic review of the literature
Rea-Neto, A., Youssef, N. C. M., Tuche, F., Brunkhorst, F., Ranieri, V. M., Reinhart, K., & Sakr, Y. (2008) · Critical Care · doi:10.1186/cc6877 · Cited by 266
Self-citationA rational approach to fluid therapy in sepsis
Marik, P., & Bellomo, R. (2016) · British Journal of Anaesthesia · doi:10.1093/bja/aev349 · Cited by 261
Ventilator-induced lung injury: The anatomical and physiological framework
Gattinoni, L., Protti, A., Caironi, P., & Carlesso, E. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181f1fcf7 · Cited by 261
Ulla, M., Pizzolato, E., Lucchiari, M., Loiacono, M., Soardo, F., Forno, D., Morello, F., Lupia, E., Moiraghi, C., Mengozzi, G., et al. (2013) · Critical Care · doi:10.1186/cc12847 · Cited by 260
Pathophysiology and Treatment of Septic Shock in Neonates
Wynn, J. L., & Wong, H. R. (2010) · Clinics in Perinatology · doi:10.1016/j.clp.2010.04.002 · Cited by 260
Activation and Regulation of Systemic Inflammation in ARDS
Meduri, G. U., Annane, D., Chrousos, G. P., Marik, P. E., & Sinclair, S. E. (2009) · Chest · doi:10.1378/chest.08-2408 · Cited by 260
Fever Control Using External Cooling in Septic Shock: A Randomized Controlled Trial
Schortgen, F., Clabault, K., Katsahian, S., Devaquet, J., Mercat, A., Deye, N., Dellamonica, J., Bouadma, L., Cook, F., Beji, O., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201110-1820oc · Cited by 259
Self-citation
Metadata
- Authors
- Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., Calandra, T., Dhainaut, J.-F., Gerlach, H., Harvey, M., Marini, J. J., Marshall, J., Ranieri, M., Ramsay, G., Sevransky, J., Thompson, B. T., Townsend, S., Vender, J. S., Zimmerman, J. L., & Vincent, J.-L.
- Venue
- Intensive Care Medicine
- Published
- 2007-12-04
- Volume
- 34
- Issue
- 1
- Pages
- 17-60
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2118858814
- Cited by
- 6,772
- References
- 375
- FWCI
- 311.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.